Assessing the Risk of Developing Type II Diabetes Using Serum Biomarkers in Patients Diagnosed With Obstructive Sleep Apnea (OSA & DM)

Share this content:

Assessing the Risk of Developing Type II Diabetes Using Serum Biomarkers in Patients Diagnosed With Obstructive Sleep Apnea (OSA & DM)

Sponsors and Collaborators
Mike O'Callaghan Federal Hospital

Contact
Jill M Teixeira, MBA/HCM, CCRP, CCRC
(702) 653-2756
jill.teixeira@nellis.af.mil

Principal Investigator
Brendan Lucey, M.D., Maj, Mike O'Callaghan Federal Hospital/Nellis AFB

ClinicalTrials.gov Identifier
NCT01447251

You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters